PUPH, Université Lyon1 (ISPB-Faculté de Pharmacie) et Hospices Civils de Lyon
1
R. Prasad Adhikary
1
REACT Cameroun
1
Reliefweb OCHA Services
1
REMM, RITN
1
Results for Development (R4D)
1
Roberton, T.
1
Romanello M., McGushin A., et al.
1
Royal Government of Cambodia
1
Ruff, P.
1
Ruth Naylor
1
S. Kumar Rai
1
S. Lordemus
1
S. Phanouvong, C. Raymond, L. Krech, Y. Dijiba, B. Mam, P. Lukulay, D. Socheat, T. Sovannarith and C. Sokhan
1
S. Sweeney
1
Sachs, J.
1
SAHPRA
1
Sameh Saleeb, Seydou Doumbia
1
Sana-Al-Sukhun, C. Blanchard, et al.
1
Sangeeta Raja and Nadeem Mohammad
1
Scarpetta, Stefano
1
Serneels, P., Montalvo, J.G., Pettersson, G., et al.
1
Sharifa Begum, et al.
1
SIAPS
1
Sophie Witter, Nouria Brikci, Tim Harris, et al.
1
South African Medical Journey SAMJ
1
Southeast asian J trop med public health
1
Southern African HIV Clinicians Society
1
Stop TB Partnership
1
Swedish International Agricultural Network Initiative SIANI
1
Syed, Shamsuzzoha
1
Syrian Centre for Policy Research (SCPR)
1
Tanzania Food & Drugs Authority (TFDA)
1
Tanzania Ministry of Health, Community Development, Gender, Elderly and Children.
1
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION
1
The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu
1
the Government of Sierra Leone, the Medical Research Centre, the University of Sierra Leone, the Royal Tropical Institute (KIT), Text to Change, and MannionDaniels
1
The Government of Uganda
1
The Government of Zambia
1
The Independent Panel
1
The Republic of Tajikistan
1
The Republic of the Union of Myanmar, Ministry of Health
1
The Republic of the Union of Myanmar, Ministry of Health and Sports
1
The Uganda Gazette
1
Thriemer K, Katuala Y, Batoko B, Alworonga J-P, Devlieger H, et al.
1
Ties Boerma, Colin Mathers, Carla AbouZahr, Somnath Chatterji, Daniel Hogan and Gretchen Stevens
1
Torres-Rueda S.
1
Treatment Action Group
1
Tufts University, Oxfam
1
U.S. Agency for International Development (USAID)
1
U.S. Global Malaria Coordinator
1
Umited Nations Popuilation Fund UNFPA
1
UN Development Programme
1
UN Environment Programme
1
UN Interregional Crime and Justice Research Institute UNICRI
1
UN Sustainable Development Solutions Network (SDSN)
1
UNAIDS (Joint United Nations Programme on HIV/AIDS)
1
UNCEN, UNIPA, SMERU, BPS, UNICEF
1
UNHCR
1
UNICEF and UNFPA
1
UNICEF Supply Division
1
United Nations Children's Fund (UNICEF)
1
United Nations Economic Commission for Europe
1
United Nations Industrial Develoopment Organization
1
United Nations Office on Drug and Crime UNODOC
1
United States Agency for International Development (USAID), SIAPS
1
University of Sheffield
1
UNRWA
1
Uppsala Monitoring Centre
1
USAID Deliver Project
1
USAID, SPS, Strengthening Pharmaceutical Systems Program-Kenya
1
USAID, Deliver Project
1
USAID, SIAPS
1
USAID, SPS
1
Valérie Arnould
1
Veillard, Jeremy Henri Maurice
1
Vikram Patel, Dan Chisholm, Tarun Dua et al.
1
WHO Regional Office for Africa
1
WHO, Pan American Health Organization
1
Wilson, Dave
1
World bank group
1
World Food Program WFP
1
World Health Organisation (WHO) Regional Office for Africa
1
World Health Organisation WHO
1
World Health Organization (WHO), International Pharmaceutical Federation (FIP)
1
World Health Organization (WHO), Kenya Country Office
1
World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), and The World Bank
1
World Health Organization (WHO), Regional Office for South East Asia
1
World Health Organization and Calouste Gulbenkian Foundation
1
World Health Organization Europe
1
World Health Organization, Europe
1
World Health Organization, Regional Office for Africa
1
World Health Organization, South-East Asia
1
World Health Organization, United Nations Children's Fund, United Nations Development Programme, United Nations Populations Fund, World Bank
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...e-related adverse effects in humans, promoting patient safety, and the rational use of medicines. The indicators proposed in this manual are based on the expected functions of pharmacovigilance centres as described in the WHO Mimimum Requirements for a Functional Pharmacovigilance System (1) (see Annex 1 of the manual).more
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...opulation has lost ground since the 1990s in virtually all important health indicators, leaving South Africa with a high burden of infectious disease.
August 2011, Vol. 101, No. 8 SAMJmore
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...f medicines’ benefit and harm help to achieve the ultimate goal of safe and effective treatments available to patients.
The guideline is intended to assist healthcare professionals in the reporting of suspected adverse drug reactions (ADRs) associated with the use of all registered health products, including medicines, old medicines, medical devices and in-vitro diagnostics (IVDs).more
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...ions caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.more
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a...nd treatment - is a critical component of malaria prevention and control. To achieve the main objective of reducing malaria morbidity and prevention of malaria mortality, the availability of safe, effective, affordable and accessible anti-malarial drugs is a prerequisite.more
Aboud S., R. MdegelaGlobal Antibiotic Resistance Partnership—Tanzania Working Group
(2015)
C2
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...antimicrobial drugs. The rapid rate with which antimicrobial agents are becoming ineffective due to resistance acquired as a result of unchecked overuse and misuse threatens to undo the benefit of controlling infections. The evidence for resistant microorganisms, many times to more than a single antimicrobial agent, has been observed globally. In Tanzania, there is evidence in the form of few scattered studies conducted in different parts of the country in a multitude of settings including health care facilities, the community, domesticated animals and wild animalsmore
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...ther-ing original data and information from Member States, in supporting the process of aggregation of these data; and in reviewing the regional analysis of the findings that reflect the country situation at the point when the survey was conducted. The support and commitment of the members of the WHO Task Force on Antimicrobial Resistance, comprising WHO staff from Headquarters and Regional Offices has, is also acknowledged.more
World Health OrganizationWorld Health Organization, United Nations Children's Fund, United Nations Development Programme, United Nations Populations Fund, World Bank
(2007)
C_WHO
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...ion of pharmaceutical products.more
his practical Guide serves as a companion to the “WHO guideline: recommendations on digital interventions for health system strengthening” and provides a systematic process for countries to develop a costed implementation plan for digital health within one or more health programme areas, drawing... guidance from the WHO guideline–recommended digital health interventions, providing direction to ensure investments are needs-based and contribute effective and interoperable systems aligned with national digital architecture, country readiness, health system and policy goals.more